We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) to Issue Senior Notes Worth $750 Million
Read MoreHide Full Article
Tenet Healthcare Corp. (THC - Free Report) recently announced its decision to sell aggregate principal amount of newly issued senior secured second lien notes worth $750 million through a private placement. The company also established the pricing of the senior secured second lien notes, due 2022. The $750 million aggregate principal amount of the notes, has been upsized from $500 million and will carry an interest rate of 7.50% per annum.
The notes will be secured on a second lien priority basis on the capital stock. These notes will be senior to the company’s unsecured debt and subordinated to the first-lien secured debt.
The net proceeds of the issuance of these notes will be primarily used for the payment of fees and expenses. The remainder, if any, will be used to repay outstanding debt under Tenet Healthcare’s senior secured revolving credit facility and for other general corporate purposes.
Tenet Healthcare is a highly levered company and it regularly refinances debt through tender offers and exchange offers. It also repurchases debt through privately negotiated transactions and open market repurchases. As of Sep 30, 2016, the company had a total debt of $14.3 billion as against total shareholders’ equity of $528 million. The debt level remained almost same year over year. The company deploys substantial part of its cash flow to pay the interests on its debts and thus, is left with limited funds to utilize for its operations, growth initiatives or capital expenditures. Previous to this pricing, the company offered to sell $500 million aggregate principal amount of senior secured notes through a private placement in Jun 2016.
Investors can also look at some better-ranked stocks from the medical sector like WellCare Health Plans Inc. , Magellan Health Inc. and Humana Inc. (HUM - Free Report) .
Magellan delivered positive surprise in three of the last four quarters with an average beat of 42.58%. The company sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
WellCare delivered beat through out last four quarters with an average of 40.01%. the company also has a Zacks Rank #1.
Humana delivered positive surprise in three of the last four quarters with an average beat of 1.94%. It carries a Zacks Rank #2 (Buy).
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>
See More Zacks Research for These Tickers
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Tenet Healthcare (THC) to Issue Senior Notes Worth $750 Million
Tenet Healthcare Corp. (THC - Free Report) recently announced its decision to sell aggregate principal amount of newly issued senior secured second lien notes worth $750 million through a private placement. The company also established the pricing of the senior secured second lien notes, due 2022. The $750 million aggregate principal amount of the notes, has been upsized from $500 million and will carry an interest rate of 7.50% per annum.
The notes will be secured on a second lien priority basis on the capital stock. These notes will be senior to the company’s unsecured debt and subordinated to the first-lien secured debt.
The net proceeds of the issuance of these notes will be primarily used for the payment of fees and expenses. The remainder, if any, will be used to repay outstanding debt under Tenet Healthcare’s senior secured revolving credit facility and for other general corporate purposes.
Tenet Healthcare is a highly levered company and it regularly refinances debt through tender offers and exchange offers. It also repurchases debt through privately negotiated transactions and open market repurchases. As of Sep 30, 2016, the company had a total debt of $14.3 billion as against total shareholders’ equity of $528 million. The debt level remained almost same year over year. The company deploys substantial part of its cash flow to pay the interests on its debts and thus, is left with limited funds to utilize for its operations, growth initiatives or capital expenditures. Previous to this pricing, the company offered to sell $500 million aggregate principal amount of senior secured notes through a private placement in Jun 2016.
TENET HEALTH Price
TENET HEALTH Price | TENET HEALTH Quote
Zacks Rank and Stocks to Consider
Tenet Healthcare presently carries Zacks Rank #3 (Hold).
Investors can also look at some better-ranked stocks from the medical sector like WellCare Health Plans Inc. , Magellan Health Inc. and Humana Inc. (HUM - Free Report) .
Magellan delivered positive surprise in three of the last four quarters with an average beat of 42.58%. The company sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
WellCare delivered beat through out last four quarters with an average of 40.01%. the company also has a Zacks Rank #1.
Humana delivered positive surprise in three of the last four quarters with an average beat of 1.94%. It carries a Zacks Rank #2 (Buy).
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>